409 related articles for article (PubMed ID: 6103653)
21. 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.
Kornhuber J; Riederer P; Reynolds GP; Beckmann H; Jellinger K; Gabriel E
J Neural Transm; 1989; 75(1):1-10. PubMed ID: 2563750
[TBL] [Abstract][Full Text] [Related]
22. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro].
Oelssner W; Peinhardt G; Büge A
Pharmazie; 1985 May; 40(5):341-2. PubMed ID: 2863832
[TBL] [Abstract][Full Text] [Related]
23. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
Hamblin MW; Creese I
Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
[TBL] [Abstract][Full Text] [Related]
24. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
Bacopoulos NG
J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
[TBL] [Abstract][Full Text] [Related]
25. Central nervous system dopamine receptors.
Creese I
Adv Biochem Psychopharmacol; 1980; 21():235-42. PubMed ID: 6103649
[No Abstract] [Full Text] [Related]
26. [The binding of 3H-spiperone to lymphocytes in patients with schizophrenia and first-degree relatives: in search of a genetic marker].
Heinze G; King GB; Huerto L; Ortega H; Cortés J; Ariza JR
Gac Med Mex; 1994; 130(4):241-5. PubMed ID: 8964331
[TBL] [Abstract][Full Text] [Related]
27. Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain.
Altar CA; Wasley AM; Neale RF; Stone GA
Brain Res Bull; 1986 Apr; 16(4):517-25. PubMed ID: 2872945
[TBL] [Abstract][Full Text] [Related]
28. Neuroleptics have identical potencies in human brain limbic and putamen regions.
Seeman P; Ulpian C
Eur J Pharmacol; 1983 Oct; 94(1-2):145-8. PubMed ID: 6140171
[TBL] [Abstract][Full Text] [Related]
29. Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report.
Wong DF; Wagner HN; Pearlson G; Dannals RF; Links JM; Ravert HT; Wilson AA; Suneja S; Bjorvvinssen E; Kuhar MJ
Psychopharmacol Bull; 1985; 21(3):595-8. PubMed ID: 4034877
[No Abstract] [Full Text] [Related]
30. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
[TBL] [Abstract][Full Text] [Related]
31. [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y
Eur J Pharmacol; 1984 Mar; 99(2-3):167-75. PubMed ID: 6734727
[TBL] [Abstract][Full Text] [Related]
32. Brain receptors for dopamine and neuroleptics.
Seeman P; Titeler M; Tedesco J; Weinreich P; Sinclair D
Adv Biochem Psychopharmacol; 1978; 19():167-76. PubMed ID: 29446
[No Abstract] [Full Text] [Related]
33. Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors?
Crow TJ; Cross AJ; Johnstone EC; Owen F; Owens DG; Waddington JL
J Clin Psychopharmacol; 1982 Oct; 2(5):336-40. PubMed ID: 7130435
[TBL] [Abstract][Full Text] [Related]
34. Selective labeling of apomorphine receptors by 3H-LSD.
Whitaker PM; Seeman P
Eur J Pharmacol; 1979 Jun; 56(3):269-71. PubMed ID: 225177
[TBL] [Abstract][Full Text] [Related]
35. Direct evidence for presynaptic and postsynaptic dopamine receptors in brain.
Nagy JI; Lee T; Seeman P; Fibiger HC
Nature; 1978 Jul; 274(5668):278-81. PubMed ID: 683308
[No Abstract] [Full Text] [Related]
36. Hallucinogen binding to dopamine/neuroleptic receptors.
Whitaker PM; Seeman P
J Pharm Pharmacol; 1977 Aug; 29(8):506-7. PubMed ID: 19605
[No Abstract] [Full Text] [Related]
37. Dopamine and noradrenaline in post-mortem brain in Huntington's disease and schizophrenic illness.
Bird ED; Spokes EG; Iversen LL
Acta Psychiatr Scand Suppl; 1980; 280():63-73. PubMed ID: 6447433
[No Abstract] [Full Text] [Related]
38. Dopamine receptors and schizophrenia: drug effect or illness?
Mackay AV; Bird ED; Spokes EG; Rossor M; Iversen LL; Creese I; Snyder SH
Lancet; 1980 Oct; 2(8200):915-6. PubMed ID: 6107564
[No Abstract] [Full Text] [Related]
39. Bimodal distribution of dopamine receptor densities in brains of schizophrenics.
Seeman P; Ulpian C; Bergeron C; Riederer P; Jellinger K; Gabriel E; Reynolds GP; Tourtellotte WW
Science; 1984 Aug; 225(4663):728-31. PubMed ID: 6147018
[TBL] [Abstract][Full Text] [Related]
40. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
Farde L; Wiesel FA; Stone-Elander S; Halldin C; Nordström AL; Hall H; Sedvall G
Arch Gen Psychiatry; 1990 Mar; 47(3):213-9. PubMed ID: 1968328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
